EC:3.4.21.6 - FACTA Search

Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Target Concepts:

Query: EC:3.4.21.6 (thromboplastin)
13,278 document(s) hit in 31,850,051 MEDLINE articles (0.01 seconds)

.

Concepts found in the documents ranked by [ Frequency | Pointwise Mutual Information | Symmetric Conditional Probability ] .

Human Gene/Protein
DC43	11.2
factor Xa	11.2
thromboplastin	11.1
effector cell protease receptor-1	10.9
protein Z-dependent protease inhibitor	10.4
FGL2 protein	10.2
heparan sulfate 3-O-sulfotransferase 1	10.2
X mRNA	9.9
Coagulation factor V	9.8
Prothrombin	9.6
prothrombin	9.6
ZPI	9.5
proteinase inhibitor 8	9.4
tissue factor pathway inhibitor	9.4
thrombin inhibitor	9.1
factor V	9.0
NAP5	9.0
EPR-1	9.0
Fibrinogen-like protein 2	9.0
coagulation factor X	8.9
SERPINB12	8.9
heparin cofactor II	8.8
FGL2	8.8
proaccelerin	8.8
antithrombin	8.8
factor XI	8.7
3-OST-5	8.6
SAPS3	8.6
putative dipeptidase	8.6
FVT1	8.6
zinc finger protein 165	8.6
Antithrombin	8.6
factor VII	8.6
Antithrombin-III	8.6
antithrombin III	8.6
Coagulation factor X	8.5
Coagulation factor XII	8.5
coagulation factor V	8.5
protein Z	8.4
factor XII	8.4

Disease
Anticoagulant-induced bleeding	11.2
Passovoy factor deficiency	11.2
RP34	11.2
Acquired coagulation factor deficiency	10.2
von Willebrand disease type 2	10.2
Fletcher trait	9.9
Acquired factor VIII deficiency	9.8
Acquired hemophilia	9.5
Owren	9.3
Systemic fibrinogenolysis	9.2
Citrate toxicity	9.2
Non-ST elevation myocardial infarction (NSTEMI)	9.2
hereditary factor VII deficiency	9.2
Factor XII deficiency	9.1
circulating anticoagulants	9.1
Severe hemophilia A	8.9
HPC4	8.9
Acquired dysfibrinogenemia	8.9
Hepatic lymphoma	8.9
Acyanotic congenital heart disease	8.9
Erythrocytopenia	8.9
EGMA	8.8
clotting factor deficiency	8.7
Drug-induced hemolytic anemia	8.6
gray syndrome	8.6
hyperheparinemia	8.6
WFS2	8.6
Acute biphenotypic leukemia	8.6
Diffuse hypertrophy	8.6
Factor VII deficiency	8.6
Scott syndrome	8.6
hypoprothrombinemia	8.5
Acute coagulopathy	8.4
Acquired von Willebrand syndrome	8.2
Primary antiphospholipid syndrome	8.2
F5F8D	7.9
Coombs negative hemolytic anemia	7.9
Neurological morbidity	7.6
hypofibrinogenemia	7.5
vitamin K deficiency	7.5

Drug
Cyclotheonamide A	11.2
Sodium dehydroacetate	11.2
Normiflo	10.6
Napsagatran	10.2
Ozagrel sodium	10.2
Ardeparin	10.0
Fondaparinux	9.8
Apixaban	9.7
Nonacog alfa	9.6
Desirudin	9.5
Clivarine	9.2
Argatroban	9.1
Hirulog	8.9
Pentastarch	8.9
Carbetimer	8.9
Orgaran	8.8
Heparin sodium	8.7
Ximelagatran	8.7
Lepirudin	8.7
Fragmin	8.6
Lovenox	8.5
RBT	8.4
Abetimus sodium	8.2
Dalteparin	8.2
Calciparine	8.1
Protamine sulfate	8.1
LMWH	7.9
Thrombostat	7.9
Hydroxyethylstarch	7.8
Ethamsylate	7.8
Antithrombin III	7.7
Propylene glycol alginate	7.6
Kaolin	7.4
Bivalirudin	7.4
Desmopressin acetate	7.3
Vitamin K	7.3
Ferric oxide	7.2
Colestimide	7.2
Phenprocoumon	7.0
Pentosan polysulfate sodium	6.9

Enzyme
thromboplastin	11.2
RVV-V	9.8
coagulation factor IXa	9.1
coagulation factor XIa	9.0
cancer procoagulant	8.5
thrombin	8.3
clotting enzyme	8.1
coagulation factor VIIa	7.9
Hageman factor	7.8
atrolysin C	7.3
glucosaminyl 3-O-sulfotransferase	7.2
glucosaminyl 3-O-sulfotransferase	7.2
thrombin-activatable fibrinolysis inhibitor	7.1
UDP-N-acetylmuramate:L-alanine ligase	7.1
APC	6.9
glycuronidase	6.7
heparinase	6.7
plasmin	6.6
hypodermin C	6.6
kallikrein	6.3
clavaminate synthase	6.3
rubredoxin reductase	6.3
C1 esterase	6.2
tissue kallikrein	6.1
tissue plasminogen activator	6.0
destabilase	5.9
heparitinase I	5.8
staphopain	5.8
prozyme	5.8
ancrod	5.7
hepsin	5.6
hepsin	5.6
enterokinase	5.5
PdxH	5.5
matriptase	5.5
ficin	5.4
GP-I	5.3
chondroitinase B	5.3
urokinase-type plasminogen activator	5.1
matriptase	5.1